We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$112B
AUM Growth
+$9.72B
Cap. Flow
+$4.75B
Cap. Flow %
4.26%
Top 10 Hldgs %
20.07%
Holding
4,187
New
244
Increased
1,335
Reduced
1,929
Closed
426

Sector Composition

Rank Sector Weight
1 Technology 11.35%
2 Healthcare 10.59%
3 Financials 10.23%
4 Industrials 7.49%
5 Consumer Discretionary 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXD
3901
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
-14,100
Closed -$2.67M
CASA
3902
DELISTED
Casa Systems, Inc. Common Stock
CASA
-19,114
Closed -$312K
NETI
3903
DELISTED
Eneti Inc.
NETI
-1,877
Closed -$123K
ACGN
3904
DELISTED
Aceragen Inc
ACGN
-368
Closed -$66K
GLOP
3905
DELISTED
GASLOG PARTNERS LP
GLOP
-11,437
Closed -$273K
BLCM
3906
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-2,133
Closed -$158K
VYNT
3907
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
-67
Closed -$9K
JNCE
3908
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-11,867
Closed -$91K
AGFS
3909
DELISTED
AgroFresh Solutions Inc
AGFS
-10,436
Closed -$73K
CEA
3910
DELISTED
China Eastern Airlines
CEA
-5,887
Closed -$201K
DS
3911
DELISTED
Drive Shack Inc.
DS
-18,260
Closed -$141K
HIL
3912
DELISTED
Hill International, Inc. Common Stock
HIL
-12,591
Closed -$74K
ZVO
3913
DELISTED
Zovio Inc. Common Stock
ZVO
-187,289
Closed -$1.22M
TMBR
3914
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
-3
Closed -$11K
CCXI
3915
DELISTED
ChemoCentryx, Inc.
CCXI
-14,279
Closed -$187K
AMPE
3916
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-77
Closed -$51K
TYME
3917
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
-11,149
Closed -$35K
ATHX
3918
DELISTED
Athersys, Inc. Common Stock
ATHX
-1,203
Closed -$59K
XELA
3919
DELISTED
Exela Technologies, Inc. Common Stock
XELA
-1
Closed -$65K
GPL
3920
DELISTED
Great Panther Mining Limited
GPL
-1,184
Closed -$14K
MBII
3921
DELISTED
Marrone Bio Innovations, Inc.
MBII
-14,054
Closed -$26K
ATRS
3922
DELISTED
Antares Pharma, Inc.
ATRS
-37,436
Closed -$96K
SRGA
3923
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
-512
Closed -$70K
CONE
3924
CALL
DELISTED
CyrusOne Inc Common Stock
CONE
-7,600
Closed -$444K
NEW
3925
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
-5,000
Closed -$1.07M

Similar funds

Credit Suisse's Q3 2018 Portfolio in Review

As of Q3 2018, Credit Suisse held 4,187 positions worth $112B, up 9.5% from $102B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Credit Suisse deployed $4.75B of net new capital in Q3 2018, opening 244 new positions and adding to 1,335 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,600,000 shares worth $109M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $281M trimmed.

  • Credit Suisse's largest Q3 2018 buy was Invesco Zacks Mid-Cap ETF: 1,600,000 shares worth $109M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $1.14B increase.
  • Credit Suisse's biggest Q3 2018 reduction was UnitedHealth, cutting an estimated $281M.
  • Credit Suisse fully exited KraneShares CSI China Internet ETF in Q3 2018, selling an estimated $137M.
  • Credit Suisse's ten largest holdings make up 20% of its $112B portfolio in Q3 2018.
  • Credit Suisse opened 244 new positions and closed 426 in Q3 2018.
  • Credit Suisse's portfolio value rose 9.5% quarter-over-quarter to $112B.

Based on Credit Suisse's 13F filing for Q3 2018, filed 13 Nov 2018.